Announcements Trials

Browse Landscape

Status

Terminated 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 1905 Breast Neoplasms 1426 Carcinoma, Non-Small-Cell Lung 1179 Prostatic Neoplasms 740 Colorectal Neoplasms 686 Neoplasm Metastasis 624 Multiple Myeloma 548 Melanoma 529 Ovarian Neoplasms 456 Lung Neoplasms 447 Lymphoma, Non-Hodgkin 385 Recurrence 374 Lymphoma 374 Leukemia, Myeloid, Acute 370 Pancreatic Neoplasms 358 Carcinoma, Renal Cell 339 Carcinoma, Hepatocellular 286 Stomach Neoplasms 281 Leukemia, Lymphocytic, Chronic, B-Cell 268 Lymphoma, Follicular 254 Head and Neck Neoplasms 246 Glioblastoma 220 Leukemia 215 Small Cell Lung Carcinoma 183 Lymphoma, Large B-Cell, Diffuse 183 Squamous Cell Carcinoma of Head and Neck 181 Urinary Bladder Neoplasms 175 Carcinoma 175 Uterine Cervical Neoplasms 174 Advanced Solid Tumors 161

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDUSTRY × Muscle-Invasive Bladder Carcinoma × Clear all

NCT05028660 2025-05-09

AUR93A

Elypta

Muscle-Invasive Bladder Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡